Chemical Structure : TSL-1502
Catalog No.: PC-27716Not For Human Use, Lab Use Only.
TSL-1502 is a glucuronide prodrug of poly (ADP-ribose) polymerase (PARP) inhibitor TSL-1502M, which is a potent PARP1 and PARP2 inhibitor with IC50 of 0.66 nM and 0.87 nM respectively.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TSL-1502 is a glucuronide prodrug of poly (ADP-ribose) polymerase (PARP) inhibitor TSL-1502M, which is a potent PARP1 and PARP2 inhibitor with IC50 of 0.66 nM and 0.87 nM respectively.
TSL-1502 prodrug has no activity on PARP1 and PARP2.
TSL-1502 could release the active parent drug TSL-1502M in cells.
TSL-1502 induces persistent DSBs, G2/M arrest and apoptosis in HR-deficient cells, and displays stronger effects than olaparib.
TSL-1502 selectively inhibits the proliferation of HR-deficient cancer cells.
TSL-1502M sensitizes both HR-deficient and HR-proficient cancer cells to conventional chemotherapy
TSL-1502 at 25 and 50 mg/kg (p.o., BID×14) exhibited profound anti-tumor activity in MX-1 (BRCA1-deficient, BRCA2-mutated) xenografts model, sensitized irinotecan anti-tumor effect.
| M.Wt | 490.56 | |
| Formula | C24H34N4O7 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Wang L, et al. Am J Cancer Res. 2021 Apr 15;11(4):1632-1645.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright